These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 16409183

  • 21. Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature.
    Cianchini G, Corona R, Frezzolini A, Ruffelli M, Didona B, Puddu P.
    Arch Dermatol; 2007 Aug; 143(8):1033-8. PubMed ID: 17709662
    [Abstract] [Full Text] [Related]

  • 22. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
    Reipert BM, van Helden PM, Schwarz HP, Hausl C.
    Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196
    [Abstract] [Full Text] [Related]

  • 23. Spontaneous disappearance of high titre factor VIII inhibitor 15 years after unsuccessful ITI.
    Thom K, Male C, Falger J, Pabinger I.
    Hamostaseologie; 2009 May; 29(2):149-50. PubMed ID: 19404512
    [Abstract] [Full Text] [Related]

  • 24. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
    Usui M, Isaji S, Mizuno S, Sakurai H, Uemoto S.
    Clin Transplant; 2007 May; 21(1):24-31. PubMed ID: 17302588
    [Abstract] [Full Text] [Related]

  • 25. Current management of acquired factor VIII inhibitors.
    Barnett B, Kruse-Jarres R, Leissinger CA.
    Curr Opin Hematol; 2008 Sep; 15(5):451-5. PubMed ID: 18695367
    [Abstract] [Full Text] [Related]

  • 26. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases.
    El-Hallak M, Binstadt BA, Leichtner AM, Bennett CM, Neufeld EJ, Fuhlbrigge RC, Zurakowski D, Sundel RP.
    J Pediatr; 2007 Apr; 150(4):376-82. PubMed ID: 17382113
    [Abstract] [Full Text] [Related]

  • 27. Rituximab in the treatment of acquired hemophilia.
    Stachnik JM.
    Ann Pharmacother; 2006 Jun; 40(6):1151-7. PubMed ID: 16735671
    [Abstract] [Full Text] [Related]

  • 28. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
    Busch M, Gerth J, Ott U, Schip A, Haufe CC, Gröne HJ, Wolf G.
    Med Klin (Munich); 2008 Jul 15; 103(7):519-24. PubMed ID: 18604487
    [Abstract] [Full Text] [Related]

  • 29. [A life-threatening cardiomyopathy following port-a-cath infection under immune tolerance therapy].
    Wiegand G, Rauch R, Girisch M, Hofbeck M.
    Hamostaseologie; 2007 Sep 15; 27(4):290-2. PubMed ID: 17938769
    [Abstract] [Full Text] [Related]

  • 30. [Immune tolerance therapy for inhibitors in haemophilia A].
    Oldenburg J.
    Hamostaseologie; 2008 Oct 15; 28 Suppl 1():S23-5. PubMed ID: 18958334
    [Abstract] [Full Text] [Related]

  • 31. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.
    Dello Strologo L, Guzzo I, Laurenzi C, Vivarelli M, Parodi A, Barbano G, Camilla R, Scozzola F, Amore A, Ginevri F, Murer L.
    Transplantation; 2009 Aug 15; 88(3):417-20. PubMed ID: 19667947
    [Abstract] [Full Text] [Related]

  • 32. Immune tolerance in hemophilia-principal results from the International Registry. Report of the factor VIII and IX Subcommittee.
    Mariani G, Ghirardini A, Bellocco R.
    Thromb Haemost; 1994 Jul 15; 72(1):155-8. PubMed ID: 7974364
    [Abstract] [Full Text] [Related]

  • 33. [Preliminary experience with achieving immune tolerance in patients with hemophilia A and circulating factor VIII inhibitor].
    Scharf R, Kucharski W, Lopaciuk S, Celińska W, Dmytrow A, Domański K, Gonet S, Miastkowski Z, Nowakowska I, Przybylski A.
    Acta Haematol Pol; 1991 Jul 15; 22(1):92-9. PubMed ID: 1823972
    [Abstract] [Full Text] [Related]

  • 34. Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two cases.
    Berezné A, Stieltjes N, Le-Guern V, Teixeira L, Billy C, Roussel-Robert V, Flaujac C, Horellou MH, Guillevin L, Mouthon L.
    Transfus Med; 2006 Jun 15; 16(3):209-12. PubMed ID: 16764602
    [Abstract] [Full Text] [Related]

  • 35. Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.
    Nilsson IM, Berntorp E, Zettervall O.
    N Engl J Med; 1988 Apr 14; 318(15):947-50. PubMed ID: 3127711
    [Abstract] [Full Text] [Related]

  • 36. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M, Sawamoto Y, Kamisue M, Shibata Y, Tuzi S, Kuwabara M, Tanaka I, Tanizawa T, Tanaka A, Ueda M, Kakishita E, Yoshioka A.
    Rinsho Ketsueki; 1996 Nov 14; 37(11):1303-8. PubMed ID: 8960666
    [Abstract] [Full Text] [Related]

  • 37. Inhibitor development and management in three non-severe haemophilia A patients with T295A variant.
    Ivaskevicius V, Goldmann G, Horneff S, Marquardt N, Klein C, Albert T, Zeitler H, Oldenburg J.
    Hamostaseologie; 2014 Nov 14; 34 Suppl 1():S9-12. PubMed ID: 25382774
    [Abstract] [Full Text] [Related]

  • 38. Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success.
    Mariani G, Kroner B, Immune Tolerance Study Group (ITSG).
    Haematologica; 2001 Nov 14; 86(11):1186-93. PubMed ID: 11694405
    [Abstract] [Full Text] [Related]

  • 39. Continuous high-dose factor VIII for the induction of immune tolerance in haemophilia A patients with high responder state: a description of eleven patients treated.
    Scheibel E, Ingerslev J, Dalsgaard-Nielsen J, Stenbjerg S, Knudsen JB.
    Thromb Haemost; 1987 Dec 18; 58(4):1049-52. PubMed ID: 3127918
    [Abstract] [Full Text] [Related]

  • 40. Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias.
    Rao A, Kelly M, Musselman M, Ramadas J, Wilson D, Grossman W, Shenoy S.
    Pediatr Blood Cancer; 2008 Apr 18; 50(4):822-5. PubMed ID: 17570702
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.